Follow-up Study of the Immunogeneity and Safety of a Live Attenuated Tetravalent Dengue Vaccine TV005 among Taiwanese Adults 50 to 70 Years of Age: a Phase II Clinical Trial = 針對台灣50-70歲老年族群之4價登革疫苗TV005第二期臨床試驗後續追蹤分析研究

2021-01-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/695590Follow-up Study of the Immunogeneity and Safety of a Live Attenuated Tetravalent Dengue Vaccine TV005 among Taiwanese Adults 50 to 70 Years of Age: a Phase II Clinical Trial = 針對台灣50-70歲老年族群之4價登革疫苗TV005第二期臨床試驗後續追蹤分析研究